11 Einträge gefunden

1. The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Aktas, Bahriye
   4. Fasching, Peter A
   5. Hartkopf, Andreas
   6. Janni, Wolfgang
   7. Kasimir-Bauer, Sabine

   2019 - Forschungsinformationssystem des UKE - frei zugänglich
2. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Pantel, Klaus
   5. Rack, Brigitte
   6. Janni, Wolfgang
   7. Fasching, Peter A

   2018 - Forschungsinformationssystem des UKE
3. Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Fehm, Tanja
   3. Janni, Wolfgang
   4. Aktas, Bahriye
   5. Fasching, Peter A
   6. Kasimir-Bauer, Sabine
   7. Milde-Langosch, Karin

   2018 - Forschungsinformationssystem des UKE - frei zugänglich
4. Clinical Relevance of Serum HER2 and Circulating Tumor Cell Detection in Metastatic Breast Cancer Patients

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Rack, Brigitte
   5. Janni, Wolfgang
   6. Fasching, Peter Andreas
   7. Solomayer, Erich-Franz

   2017 - Forschungsinformationssystem des UKE
5. Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer

   1. Banys-Paluchowski, Malgorzata
   2. Witzel, Isabell
   3. Riethdorf, Sabine
   4. Rack, Brigitte
   5. Janni, Wolfgang
   6. Fasching, Peter A
   7. Solomayer, Erich-Franz

   2017 - Forschungsinformationssystem des UKE - frei zugänglich
6. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients

   1. Stückrath, Isabel
   2. Rack, Brigitte
   3. Janni, Wolfgang
   4. Jäger, Bernadette
   5. Pantel, Klaus
   6. Schwarzenbach, Heidi

   2015 - Forschungsinformationssystem des UKE
7. Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.

   1. Schwarzenbach, Heidi
   2. Eichelser, Corinna
   3. Kropidlowski, Jolanthe
   4. Janni, Wolfgang
   5. Rack, Brigitte
   6. Pantel, Klaus

   2012 - Forschungsinformationssystem des UKE
8. Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study.

   1. Müller, Volkmar
   2. Riethdorf, Sabine
   3. Rack, Brigitte
   4. Janni, Wolfgang
   5. Fasching, Peter A
   6. Solomayer, Erich
   7. Aktas, Bahriye

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
9. Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression.

   1. Roth, Carina
   2. Pantel, Klaus
   3. Müller, Volkmar
   4. Rack, Brigitte
   5. Kasimir-Bauer, Sabine
   6. Janni, Wolfgang
   7. Schwarzenbach, Heidi

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
10. Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cancer.

    1. Müller, Volkmar
    2. Riethdorf, Sabine
    3. Rack, Brigitte
    4. Janni, Wolfgang
    5. Fasching, Peter A
    6. Solomayer, Erich
    7. Aktas, Bahriye

    2011 - Forschungsinformationssystem des UKE - frei zugänglich
11. Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer.

    1. Roth, Carina
    2. Rack, Brigitte
    3. Müller, Volkmar
    4. Janni, Wolfgang
    5. Pantel, Klaus
    6. Schwarzenbach, Heidi

    2010 - Forschungsinformationssystem des UKE - frei zugänglich